Morningstar Investment Management’s Kimberly-Clark KMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$255K Hold
2,641
0.02% 307
2026
Q1
$255K Buy
2,641
+11
+0.4% +$1.13K 0.02% 305
2025
Q4
$265K Sell
2,630
-19,717
-88% -$2.16M 0.02% 312
2025
Q3
$2.78M Buy
22,347
+18,582
+494% +$2.4M 0.1% 210
2025
Q2
$485K Buy
+3,765
New +$510K 0.04% 118
2025
Q1
Sell
-4,237
Closed -$555K 151
2024
Q4
$555K Buy
4,237
+221
+6% +$30.1K 0.04% 122
2024
Q3
$576K Sell
4,016
-6,765
-63% -$959K 0.06% 127
2024
Q2
$1.49M Sell
10,781
-345
-3% -$46.1K 0.16% 63
2024
Q1
$1.44M Hold
11,126
0.16% 67
2023
Q4
$1.35M Buy
11,126
+62
+0.6% +$7.49K 0.16% 66
2023
Q3
$1.34M Buy
11,064
+211
+2% +$27.3K 0.18% 47
2023
Q2
$1.5M Buy
10,853
+8,352
+334% +$1.16M 0.2% 46
2023
Q1
$336K Hold
2,501
0.05% 67
2022
Q4
$340K Buy
+2,501
New +$318K 0.06% 68

Other funds holding KMB

Morningstar Investment Management's KMB Position: Q2 2026 in Review

Morningstar Investment Management held its Kimberly-Clark (KMB) position steady in Q2 2026 at 2,641 shares worth $255K. The position accounts for 0.02% of the portfolio, ranked #307.

Morningstar Investment Management first reported a position in KMB in Q4 2022 and has held it in 14 quarters since. The position peaked at $2.78M in Q3 2025. 631 funds tracked by Wall St. Rank hold KMB as of Q2 2026.

  • Morningstar Investment Management held 2,641 shares of Kimberly-Clark worth $255K as of Q2 2026.
  • Morningstar Investment Management left its Kimberly-Clark share count unchanged in Q2 2026.
  • Kimberly-Clark made up 0.02% of Morningstar Investment Management's portfolio in Q2 2026, its #307 holding.
  • Morningstar Investment Management first reported a position in Kimberly-Clark in Q4 2022 and has held it in 14 quarters since.
  • Morningstar Investment Management's Kimberly-Clark position peaked at $2.78M in Q3 2025.
  • 631 funds tracked by Wall St. Rank held Kimberly-Clark as of Q2 2026.

Based on Morningstar Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.